Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Clinical trial NCT00121225 · COMPLETED

Trial details

NCT number: NCT00121225
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ciliary Body and Choroid Melanoma, Medium/Large Size Extraocular Extension Melanoma Iris Melanoma Uveal Melanoma Recurrent Intraocular Melanoma Recurrent Melanoma Stage IV Melanoma

Start date: 2005-09-01
Primary completion: 2009-03-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.